Rules must evolve to allow new drugs for early Alzheimer's
(HealthDay)—Given the shift in the focus of drug development for Alzheimer's disease toward earlier disease stages, before the onset of dementia, regulatory guidelines need to evolve, according to a perspective piece published ...
Mar 14, 2013
0
0